HYPERTRIGLYCERIDEMIA
Clinical trials for HYPERTRIGLYCERIDEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERTRIGLYCERIDEMIA trials appear
Sign up with your email to follow new studies for HYPERTRIGLYCERIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot every 3 months could tame high blood fats
Disease control OngoingThis Phase 3 study tests plozasiran, an injectable drug, in 1456 adults with high triglycerides. Participants receive 4 doses over 12 months. The goal is to see if the drug safely lowers blood fat levels compared to a placebo.
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New injection aims to melt dangerous neck plaques in High-Fat patients
Disease control ENROLLING_BY_INVITATIONThis study tests an injected drug called DR10624 in 40 adults with high triglycerides and fatty buildup in their neck arteries. Participants receive either the drug or a placebo for 24 weeks, with doses gradually increased. The main goal is to see if the drug reduces artery wall …
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: NA • Sponsor: Junbo Ge • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug MAR001 aims to tackle stubborn high triglycerides
Disease control OngoingThis Phase 2b study tests whether the experimental drug MAR001 can lower high triglycerides and remnant cholesterol in adults. About 216 participants will receive either MAR001 or a placebo by injection. The main goal is to see if MAR001 reduces triglyceride levels more than plac…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Marea Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Electric muscle training may tame high blood pressure without pills
Disease control OngoingThis study tests whether whole-body electromyostimulation (WB-EMS), a technology that stimulates muscles with mild electrical pulses, can lower resting blood pressure and improve other heart risk factors in overweight adults aged 50+ with mild hypertension. Over 12 weeks, 28 part…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: NA • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug Kylo-12 enters first human safety trial for high cholesterol fats
Disease control OngoingThis early-stage study tests a new drug called Kylo-12 in 50 healthy volunteers to see if it is safe and how the body processes it. The drug aims to lower high triglycerides, a type of fat in the blood linked to heart problems. Participants receive either a single shot of Kylo-12…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE1 • Sponsor: Kylonova (Xiamen) Biopharma co., LTD. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New pill aims to tackle fatty liver and diabetes at once
Disease control OngoingThis phase 2 trial tests an oral drug called MN-001 (tipelukast) in 40 adults with non-alcoholic fatty liver disease, type 2 diabetes, and high triglycerides. Participants take either the drug or a placebo daily for 24 weeks. The study measures changes in liver fat and blood fat …
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: MediciNova • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New shot aims to tame dangerous fat levels in blood
Disease control OngoingThis study tests a single dose of a new drug called RN0361 in 108 adults. It includes healthy volunteers and people with very high triglycerides, a type of fat in the blood that can cause serious health problems. The goal is to see if the drug is safe and lowers fat levels. This …
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE1, PHASE2 • Sponsor: Ikaria Bioscience Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Teen artery stiffness study tests carnitine supplement for heart health
Disease control OngoingThis study looks at whether a protein supplement called carnitine can reduce hardening of the arteries in teenagers at high risk for future heart disease. About 90 teens aged 11-21 with high triglycerides will take carnitine or a placebo. Researchers will measure artery stiffness…
Matched conditions: HYPERTRIGLYCERIDEMIA
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC